MA43184A - Composition liposomale et son procédé de production - Google Patents

Composition liposomale et son procédé de production

Info

Publication number
MA43184A
MA43184A MA043184A MA43184A MA43184A MA 43184 A MA43184 A MA 43184A MA 043184 A MA043184 A MA 043184A MA 43184 A MA43184 A MA 43184A MA 43184 A MA43184 A MA 43184A
Authority
MA
Morocco
Prior art keywords
production process
liposomal composition
liposomal
composition
production
Prior art date
Application number
MA043184A
Other languages
English (en)
Inventor
Hiroyuki Kitaoka
Mikinaga Mori
Kentaro Numajiri
Takahiro Sekiguchi
Original Assignee
Fujifilm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp filed Critical Fujifilm Corp
Publication of MA43184A publication Critical patent/MA43184A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA043184A 2015-11-02 2016-11-01 Composition liposomale et son procédé de production MA43184A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015215767 2015-11-02

Publications (1)

Publication Number Publication Date
MA43184A true MA43184A (fr) 2021-04-14

Family

ID=58662894

Family Applications (1)

Application Number Title Priority Date Filing Date
MA043184A MA43184A (fr) 2015-11-02 2016-11-01 Composition liposomale et son procédé de production

Country Status (5)

Country Link
US (2) US20180243215A1 (fr)
EP (1) EP3372223B1 (fr)
JP (2) JP6564873B2 (fr)
MA (1) MA43184A (fr)
WO (1) WO2017078009A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3138555T3 (da) 2014-04-30 2020-12-14 Fujifilm Corp Liposomsammensætning og fremgangsmåde til fremstilling heraf
MA43184A (fr) 2015-11-02 2021-04-14 Fujifilm Corp Composition liposomale et son procédé de production
FI3811949T3 (fi) 2018-06-20 2024-09-13 Fujifilm Corp Liposomikoostumukseen kapseloitua gemsitabiinia ja immuunitarkistuspistesalpaajaa käsittävä yhdistelmälääke
PL4129304T3 (pl) 2020-04-03 2025-01-13 Fujifilm Corporation Środek przeciwnowotworowy
JPWO2025094963A1 (fr) 2023-10-31 2025-05-08
CN117338955A (zh) * 2023-11-06 2024-01-05 福建医科大学附属协和医院 一种B7-H3靶向的pH敏感脂质体的制备方法及其用途

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2566559A (en) * 1951-09-04 Preparation of agetals
JP2931981B2 (ja) * 1988-03-04 1999-08-09 武田薬品工業株式会社 リポソーム製剤およびその製造法
CA1335348C (fr) 1988-03-04 1995-04-25 Yasuaki Ogawa Composition liposomique
US5153000A (en) * 1988-11-22 1992-10-06 Kao Corporation Phosphate, liposome comprising the phosphate as membrane constituent, and cosmetic and liposome preparation comprising the liposome
US5049392A (en) * 1989-01-18 1991-09-17 The Liposome Company, Inc. Osmotically dependent vesicles
IS1685B (is) 1990-12-11 1998-02-24 Bracco International B.V. Aðferð við að búa til fitukúlur (liposomes) sem eru gæddar auknum hæfileika til að draga í sig og halda í sér aðskotaefnum
US5993850A (en) 1994-09-13 1999-11-30 Skyepharma Inc. Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances
EP0825852B1 (fr) * 1995-04-18 2004-07-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Procede de chargement de medicaments dans des liposomes et composition
DE19813773A1 (de) 1998-03-27 1999-09-30 Clemens Unger Verfahren zur Herstellung von liposomalen Wirkstoffformulierungen
US6726925B1 (en) * 1998-06-18 2004-04-27 Duke University Temperature-sensitive liposomal formulation
JP2000302685A (ja) * 1999-02-18 2000-10-31 Sankyo Co Ltd 抗腫瘍薬含有リポソーム製剤
US6727475B2 (en) * 2001-07-27 2004-04-27 Eastman Kodak Company Heating control system which minimizes AC power line voltage fluctuations
US7476400B2 (en) 2001-11-13 2009-01-13 Ferndale Ip, Inc. High-concentration lidocaine compositions and methods for their preparation
US20030198664A1 (en) * 2002-03-29 2003-10-23 Sullivan Sean Michael Lipid mediated screening of drug candidates for identification of active compounds
EP1608337A2 (fr) * 2003-04-02 2005-12-28 Celator Technologies Inc. Compositions combinees de camptothecines et de fluoropyrimidines
WO2005021012A1 (fr) * 2003-08-29 2005-03-10 Terumo Kabushiki Kaisha Vecteur de medicament contenant de la gemcitabine
JP4972545B2 (ja) 2004-04-22 2012-07-11 セレーター ファーマスーティカルズ、インク． アントラサイクリン系薬剤及びシチジンアナログのリポソーム製剤
KR101462825B1 (ko) * 2004-05-03 2014-11-21 헤르메스 바이오사이언스, 인코포레이티드 약물 전달에 유용한 리포좀
AU2005251691A1 (en) * 2004-05-17 2005-12-22 Tekmira Pharmaceuticals Corporation Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
US20070082042A1 (en) * 2004-08-06 2007-04-12 Deok-Hoon Park Multiple-layered liposome and preparation method thereof
CA2581133A1 (fr) * 2004-09-20 2006-03-30 British Columbia Cancer Agency Gemcitabine libre ou encapsulee dans des liposomes seule ou en association avec de l'idarubicine libre ou encapsulee dans des liposomes
EP1813288B1 (fr) * 2004-11-18 2018-07-18 Terumo Kabushiki Kaisha Préparation thérapeutique, formule thérapeutique, et formule combinée
EP1674081A1 (fr) * 2004-12-23 2006-06-28 KTB Tumorforschungsgesellschaft mbH Préparation de nano-particules à bases lipides en utilisant une centrifuge duale et asymétrique
JP4385170B2 (ja) * 2007-07-20 2009-12-16 ロート製薬株式会社 乳化組成物
US20090047336A1 (en) 2007-08-17 2009-02-19 Hong Kong Baptist University novel formulation of dehydrated lipid vesicles for controlled release of active pharmaceutical ingredient via inhalation
WO2009059449A1 (fr) * 2007-11-05 2009-05-14 Celsion Corporation Nouveaux liposomes thermosensibles contenant des agents thérapeutiques
US8079820B2 (en) * 2008-12-18 2011-12-20 General Electric Company Blade module, a modular rotor blade and a method for assembling a modular rotor blade
PE20120923A1 (es) * 2009-03-30 2012-08-27 Eisai Randd Man Co Ltd Composiciones farmaceuticas comprendiendo liposomas que contiene eribulina o una sal del mismo
US8215869B2 (en) * 2009-07-27 2012-07-10 Terratech Consulting Ltd. Reinforced soil arch
US20130023045A1 (en) * 2010-02-03 2013-01-24 National Cancer Center Induced hepatic stem cell and process for production thereof, and applications of the cell
US9007604B2 (en) 2010-06-30 2015-04-14 Xpedite Systems, Llc System, method, and apparatus for an interactive virtual fax machine
WO2012055020A1 (fr) * 2010-10-27 2012-05-03 Ontario Institute For Cancer Research Liposomes thermosensibles
PL226015B1 (pl) * 2011-03-03 2017-06-30 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna
JP2015507019A (ja) * 2012-02-17 2015-03-05 セルシオン コーポレイション 感熱性ナノ粒子製剤およびその製造方法
US20140029493A1 (en) * 2012-07-26 2014-01-30 Sierra Wireless, Inc. Wireless Communication Interworking Function
AU2013360302C1 (en) 2012-12-12 2019-01-24 Temple University - Of The Commonwealth System Of Higher Education Compositions and methods for treatment of cancer
KR20140120218A (ko) * 2013-04-02 2014-10-13 삼성전자주식회사 혈관신생 유도 물질 전달용 조성물, 및 이를 이용하여 제작된 인공 조직
WO2015094928A1 (fr) 2013-12-17 2015-06-25 Merck Sharp & Dohme Corp. Compositions liposomales pour inhibiteurs akt allostériques
EP3138556B1 (fr) * 2014-04-30 2022-03-02 FUJIFILM Corporation Procédé de production de liposomes
EP3138558B1 (fr) * 2014-04-30 2023-06-07 FUJIFILM Corporation Composition liposomale et procédé de production associé
WO2015166985A1 (fr) * 2014-04-30 2015-11-05 富士フイルム株式会社 Composition liposomale et procédé de production associé
DK3138555T3 (da) * 2014-04-30 2020-12-14 Fujifilm Corp Liposomsammensætning og fremgangsmåde til fremstilling heraf
JP6316182B2 (ja) * 2014-12-19 2018-04-25 富士フイルム株式会社 リポソームの製造方法及びリポソーム製造装置
MA43184A (fr) 2015-11-02 2021-04-14 Fujifilm Corp Composition liposomale et son procédé de production

Also Published As

Publication number Publication date
EP3372223A1 (fr) 2018-09-12
JP6705933B2 (ja) 2020-06-03
US20180243215A1 (en) 2018-08-30
US20210128471A1 (en) 2021-05-06
JP2019178181A (ja) 2019-10-17
EP3372223B1 (fr) 2024-04-17
JPWO2017078009A1 (ja) 2018-08-09
EP3372223A4 (fr) 2018-09-12
WO2017078009A1 (fr) 2017-05-11
US12220482B2 (en) 2025-02-11
JP6564873B2 (ja) 2019-08-21

Similar Documents

Publication Publication Date Title
EP3369848C0 (fr) Suture et son procédé de production
EP3377307A4 (fr) Composition structurale et procédé
EP3704227A4 (fr) Composition et procédé
EP3369831A4 (fr) Comprimé frité et son procédé de production
EP3476886A4 (fr) Préimprégné et son procédé de production
EP3340808A4 (fr) Procédé de production de compositions édulcorantes et compositions édulcorantes
EP3632541A4 (fr) Structure fonctionnelle et procédé de production de structure fonctionnelle
EP3632549A4 (fr) Structure fonctionnelle et procédé de production de structure fonctionnelle
EP3321086A4 (fr) Gel de polyuréthane et son procédé de production
EP3357967A4 (fr) Composition de résine absorbante et son procédé de production
EP3632548A4 (fr) Structure fonctionnelle et procédé de production de structure fonctionnelle
EP3702434A4 (fr) Composition lubrifiante et son procédé de production
EP3315561A4 (fr) Hydrogel et son procédé de production
EP3438053A4 (fr) Composition filmogène et son procédé de production
EP3315578A4 (fr) Composition hydrofuge, procédé de production de composition hydrofuge, et article
EP3647295A4 (fr) Composition de béton et son procédé de production
EP3575282A4 (fr) Complexe et son procédé de production
EP3490044A4 (fr) Membrane électrolytique et son procédé de production
EP3533774A4 (fr) Brique magnésie-carbone et son procédé de production
EP3354731A4 (fr) Composition de linalool et son procédé de production
EP3265120C0 (fr) Procédé
EP3647363A4 (fr) Composition de résine et son procédé de production
EP3377033A4 (fr) Composition de mascara et procédé associé
EP3712199A4 (fr) Polysiloxane et son procédé de production
EP3377024A4 (fr) Composition de mascara et procédé associé